Modalis Therapeutics Corporation
4883.T · JPX
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | ¥4,705 | ¥3,840 | ¥9,751 | ¥17,625 |
| - Cash | ¥3,575 | ¥1,883 | ¥2,933 | ¥4,936 |
| + Debt | ¥0 | ¥413 | ¥0 | ¥0 |
| Enterprise Value | ¥1,130 | ¥2,369 | ¥6,818 | ¥12,689 |
| Revenue | ¥0 | ¥0 | ¥41 | ¥1 |
| % Growth | – | -100% | 3,581.8% | – |
| Gross Profit | ¥0 | -¥1 | -¥83 | ¥1 |
| % Margin | – | – | -205.4% | 100% |
| EBITDA | -¥2,147 | -¥2,374 | -¥2,583 | -¥668 |
| % Margin | – | – | -6,378.7% | -60,686.1% |
| Net Income | -¥1,318 | -¥2,392 | -¥2,703 | -¥739 |
| % Margin | – | – | -6,673.4% | -67,177.8% |
| EPS Diluted | -28.57 | -77.24 | -92.85 | -25.7 |
| % Growth | 63% | 16.8% | -261.3% | – |
| Operating Cash Flow | -¥1,432 | -¥2,254 | -¥1,896 | -¥747 |
| Capital Expenditures | -¥0 | -¥40 | -¥197 | -¥107 |
| Free Cash Flow | -¥1,432 | -¥2,294 | -¥2,093 | -¥855 |